loading

United Therapeutics Corp (UTHR) 最新ニュース

pulisher
Nov 15, 2025

Understanding United Therapeutics Corporation’s price movementPortfolio Risk Summary & Real-Time Sentiment Analysis - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

How United Therapeutics Corporation (UTH) stock reacts to stronger dollarRecession Risk & Risk Controlled Stock Alerts - newser.com

Nov 14, 2025
pulisher
Nov 14, 2025

Rothblatt (United Therapeutics) sells $4.7m in UTHR stock By Investing.com - Investing.com Canada

Nov 14, 2025
pulisher
Nov 13, 2025

Heatmap analysis for United Therapeutics Corporation and competitorsJuly 2025 Price Swings & Breakout Confirmation Alerts - newser.com

Nov 13, 2025
pulisher
Nov 12, 2025

United Therapeutics Executives Sell Shares Worth Over $13 Million - TradingView

Nov 12, 2025
pulisher
Nov 10, 2025

Chmn Rothblatt Files To Sell 4,000 Of United Therapeutics Corp [UTHR] - TradingView

Nov 10, 2025
pulisher
Nov 10, 2025

United Therapeutics (UTHR): Stock Up 44.4%, Strong Growth & Cash FlowNews and Statistics - IndexBox

Nov 10, 2025
pulisher
Nov 10, 2025

Is United Therapeutics Corporation (UTH) stock a top dividend aristocrat candidateJuly 2025 Sector Moves & Daily Volume Surge Signals - newser.com

Nov 10, 2025
pulisher
Nov 09, 2025

3 Reasons Investors Love United Therapeutics (UTHR) - Yahoo Finance

Nov 09, 2025
pulisher
Nov 09, 2025

Will United Therapeutics Corporation stock rally after Fed decisionsJuly 2025 Catalysts & Safe Investment Capital Preservation Plans - newser.com

Nov 09, 2025
pulisher
Nov 08, 2025

United Therapeutics’ AI-Driven Study: A Potential Game-Changer for Pulmonary Hypertension Diagnosis - MSN

Nov 08, 2025
pulisher
Nov 08, 2025

United Therapeutics Corp’s Earnings Call Highlights Growth and Innovation - MSN

Nov 08, 2025
pulisher
Nov 07, 2025

United Therapeutics Chairperson & CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView

Nov 07, 2025
pulisher
Nov 07, 2025

United Therapeutics CorporationCommon Stock (Nasdaq:UTHR) Stock Quote - Markets Financial Content

Nov 07, 2025
pulisher
Nov 07, 2025

P/E Ratio Insights for United Therapeutics - Benzinga

Nov 07, 2025
pulisher
Nov 07, 2025

Is United Therapeutics Corp Gaining or Losing Market Support? - Sahm

Nov 07, 2025
pulisher
Nov 06, 2025

United Therapeutics Corporation (UTHR) Stock Forecasts - Yahoo! Finance Canada

Nov 06, 2025
pulisher
Nov 06, 2025

UBS Maintains United Therapeutics (UTHR) Buy Recommendation - Nasdaq

Nov 06, 2025
pulisher
Nov 06, 2025

[Form 4] UNITED THERAPEUTICS Corp Insider Trading Activity - Stock Titan

Nov 06, 2025
pulisher
Nov 05, 2025

Why United Therapeutics Corporation stock is trending among retail tradersMarket Growth Report & Daily Profit Maximizing Trade Tips - Fundação Cultural do Pará

Nov 05, 2025
pulisher
Nov 05, 2025

United Therapeutics (NASDAQ:UTHR) CEO Sells $1,753,200.00 in Stock - MarketBeat

Nov 05, 2025
pulisher
Nov 05, 2025

United Therapeutics CFO Sells Over $9 Million in Company Stock - TradingView

Nov 05, 2025
pulisher
Nov 04, 2025

Will United Therapeutics Corporation stock benefit from upcoming earnings reportsQuarterly Investment Review & Advanced Technical Signal Analysis - newser.com

Nov 04, 2025
pulisher
Nov 04, 2025

Access Investment Management LLC Makes New $2.14 Million Investment in United Therapeutics Corporation $UTHR - MarketBeat

Nov 04, 2025
pulisher
Nov 04, 2025

United Therapeutics (NASDAQ: UTHR) sets Nov 10 & 18 talks at UBS, Jefferies; webcasts - Stock Titan

Nov 04, 2025
pulisher
Nov 04, 2025

United Therapeutics Corporation $UTHR Position Lessened by Bessemer Group Inc. - MarketBeat

Nov 04, 2025
pulisher
Nov 04, 2025

Combining machine learning predictions for United Therapeutics CorporationMarket Performance Recap & Verified Technical Trade Signals - newser.com

Nov 04, 2025
pulisher
Nov 03, 2025

United Therapeutics Corporation (UTHR) Stock forecasts - Yahoo Finance UK

Nov 03, 2025
pulisher
Nov 03, 2025

United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease - The Joplin Globe

Nov 03, 2025
pulisher
Nov 03, 2025

United Therapeutics (Nasdaq: UTHR) starts EXPAND with first UKidney xenotransplant - Stock Titan

Nov 03, 2025
pulisher
Nov 03, 2025

Can technical indicators confirm United Therapeutics Corporation’s reversalWeekly Stock Report & High Accuracy Swing Trade Signals - newser.com

Nov 03, 2025
pulisher
Nov 01, 2025

Insider Selling: United Therapeutics (NASDAQ:UTHR) CEO Sells 4,000 Shares of Stock - MarketBeat

Nov 01, 2025
pulisher
Nov 01, 2025

United Therapeutics Hits Day High with 9.63% Surge in Stock Price - Markets Mojo

Nov 01, 2025
pulisher
Nov 01, 2025

MSN Money - MSN

Nov 01, 2025
pulisher
Nov 01, 2025

United Therapeutics Corp. Hits New 52-Week High of $479.50 - Markets Mojo

Nov 01, 2025
pulisher
Nov 01, 2025

United Therapeutics posts record revenue but misses Q3 earnings expectations - MSN

Nov 01, 2025
pulisher
Nov 01, 2025

Focus Partners Advisor Solutions LLC Buys Shares of 1,440 United Therapeutics Corporation $UTHR - MarketBeat

Nov 01, 2025
pulisher
Oct 31, 2025

United Therapeutics CEO Martine A. Rothblatt Sells 8,000 Shares - TradingView

Oct 31, 2025
pulisher
Oct 31, 2025

Martine Rothblatt Sells 4,000 Shares of United Therapeutics (NASDAQ:UTHR) Stock - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

3rd Circ. Preview: BMW, MiLB And Sandoz Top Nov. Lineup - Law360

Oct 31, 2025
pulisher
Oct 31, 2025

United Therapeutics (NASDAQ:UTHR) Given New $423.00 Price Target at Wells Fargo & Company - MarketBeat

Oct 31, 2025
pulisher
Oct 31, 2025

Assetmark Inc. Boosts Stock Holdings in United Therapeutics Corporation $UTHR - MarketBeat

Oct 31, 2025
pulisher
Oct 30, 2025

United Therapeutics Grows Revenue, But Misses Earnings Forecast - Finimize

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics Executives Sell Shares - TradingView

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics Corp (UTHR) Q3 2025 Earnings Call Highlights: Record Revenue Growth and ... - Yahoo Finance

Oct 30, 2025
pulisher
Oct 30, 2025

Wells Fargo Maintains United Therapeutics (UTHR) Equal-Weight Recommendation - Nasdaq

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics (NASDAQ:UTHR) Reaches New 12-Month High After Better-Than-Expected Earnings - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics price target raised to $587 from $569 at RBC Capital - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics price target raised to $447 from $435 at Morgan Stanley - TipRanks

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics (UTHR) Earnings Transcript - AOL.com

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics Corporation (NASDAQ:UTHR) Q3 2025 Earnings Call Transcript - Insider Monkey

Oct 30, 2025
pulisher
Oct 30, 2025

United Therapeutics’ PHINDER Study: A Step Forward in Early Detection of Pulmonary Hypertension - MSN

Oct 30, 2025
pulisher
Oct 30, 2025

Silver Spring-based United Therapeutics reports Q3 earnings - Maryland Daily Record

Oct 30, 2025
pulisher
Oct 30, 2025

Published on: 2025-10-31 23:58:52 - newser.com

Oct 30, 2025
$144.86
price up icon 0.48%
$25.41
price down icon 0.51%
$10.72
price down icon 1.74%
drug_manufacturers_specialty_generic RDY
$13.94
price up icon 0.50%
$21.09
price down icon 4.09%
大文字化:     |  ボリューム (24 時間):